Industry reports
Editor highlights

Drug and Medication Analysis & Statistics in Spain, July 2013 (p2)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

31-60 of about 100 reports
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2013
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Emergency Contraception Market Overview in Spain

Emergency Contraception Market Overview in Spain

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

In 2009 the Spanish Government decided to allow sales of emergency contraception on an OTC basis. However, the fact the there are 17 different regions which are in charge of implementing this new law has ...

  • Industries : Drug and Medication
  • Countries : Spain
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Spain

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Spain

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

The initial outbreak of H1N1 influenza observed in Mexico in the first quarter of 2009 caused global concerns due to fears of the potential deadly consequences on humans. In Spain, until October the incidence ...

  • Industries : Drug and Medication
  • Countries : Spain
Nrt Smoking Cessation Aids Market Overview in Spain

Nrt Smoking Cessation Aids Market Overview in Spain

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

One of the primary effects of the economic slowdown in Spain has been a moderation in spending by consumers with modest incomes, especially on non-essential goods. As a result, sales through pharmacies ...

  • Industries : Drug and Medication
  • Countries : Spain
Analgesics Market Overview in Spain

Analgesics Market Overview in Spain

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

As the unemployment rate approached 18% at the end of the review period, Spaniards’ shopping habits demonstrated change, with price the key variable taken into account when making purchasing decisions. ...

  • Industries : Drug and Medication
  • Countries : Spain
Ear Care Market Overview in Spain

Ear Care Market Overview in Spain

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Around 43% of Spaniards suffer from excess ear wax, according to the latest study carried out by Laboratorios Esteve. This is considered the most important ear problem suffered by Spaniards. There is consensus ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Psoriasis - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Psoriasis - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Psoriasis - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Psoriasis - Spain Drug Forecast and Market Analysis to 2022?. ...

  • Industries : Drug and Medication
  • Countries : Spain
Vaccine Market in Spain

Vaccine Market in Spain

  • $ 652
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Spain. The study provides essential market information for decision-makers including: ...

  • Industries : Drug and Medication
  • Countries : Spain
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

  • Industries : Drug and Medication
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran
World Drug Discovery and Development: Almirall, S.A. ? Product Pipeline Review - H2 2011

World Drug Discovery and Development: Almirall, S.A. ? Product Pipeline Review - H2 2011

  • $ 1 500
  • Company report
  • April 2013
  • by Global Markets Direct

. - Product Pipeline Review - H2 2011? provides a detailed overview on the Almirall, S.A.?s research and development focus. The report includes information on current developmental pipeline, complete with ...

  • Industries : Drug and Medication
  • Countries : Spain
MarketVIEW: Typhoid travel vaccines

MarketVIEW: Typhoid travel vaccines

  • $ 4 495
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Typhoid fever is caused by Salmonella typhi bacteria that are transmitted through contaminated food and drink in conditions of poor sanitation. Without prompt treatment with antibiotics typhoid fever can ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Europe, United States, Canada, Spain, Italy, France, Germany, United Kingdom
MarketVIEW: Cholesterol vaccines

MarketVIEW: Cholesterol vaccines

  • $ 8 995
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Cardiovascular disease(s) (CVD) are prominent within the 10 leading causes of death in high-income countries. The most common manifestations of CVD are coronary heart disease (CHD), ischaemic stroke, and ...

  • Industries : Drug and Medication
  • Countries : Australia, Europe, United States, Canada, Spain, Italy, France, Germany, World, United Kingdom
PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022?. ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2013
  • by Global Data

PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022?. Human ...

  • Industries : Drug and Medication
  • Countries : Spain
Elvitegravir (HIV) - Forecast and Market Analysis to 2022

Elvitegravir (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Elvitegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Elvitegravir (HIV) - Forecast and Market Analysis to 2022?. Human ...

  • Industries : Drug and Medication
  • Countries : Japan, Brazil, China, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
The Pharmaceutical Market: Spain, Business Monitor International

The Pharmaceutical Market: Spain, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SPAIN The sharp drop in public pharmaceutical expenditure in Spain in the first fou ...

  • Industries : Drug and Medication
  • Countries : Spain
Parkinson`s Disease: World Drug Market 2013-2023

Parkinson`s Disease: World Drug Market 2013-2023

  • $ 2 390
  • Industry report
  • January 2013
  • by Visiongain

Report Details Your guide to sales outlooks and R&D for treating Parkinson's Where are treatments for Parkinson's disease heading - technological and commercial outlooks? Visiongain's updated report gives ...

  • Industries : Drug and Medication
  • Countries : World, United States, Japan, Spain, Italy, France, Germany, United Kingdom, Europe
PharmaPoint: Prostate Cancer - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Prostate Cancer - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • December 2012
  • by Global Data

PharmaPoint: Prostate Cancer - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Prostate Cancer - Spain Drug Forecast and Market Analysis ...

  • Industries : Drug and Medication
  • Countries : Spain
Forecast: Pneumococcal Vaccines

Forecast: Pneumococcal Vaccines

  • $ 11 400
  • Industry report
  • December 2012
  • by Datamonitor

This patient-based pneumococcal vaccine forecast segments the market by brand and population groups eligible for vaccination across the US, Japan, and the five major EU markets (France, Germany, Italy, ...

  • Industries : Drug and Medication
  • Countries : Japan, United States, Netherlands, Spain, Italy, France, Germany, Europe, United Kingdom
PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis

PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Spain
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • November 2012
  • by Global Data

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022 Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such ...

  • Industries : Drug and Medication
  • Countries : Japan, India, China, United States, United Kingdom, Spain, Italy, Germany, France, World, Europe, Asia
Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis

Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluarix (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : India, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis

FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?FluMist (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, United States, Spain, Italy, Germany, Europe, United Kingdom
Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis

Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Spain, France, Germany, World, Italy, Europe, United States, China
Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, Italy, France, Germany, India, United Kingdom, Spain, Europe
Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Optaflu (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Agrippal (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, Germany, India, China, World, France, Japan, United States, United Kingdom, Europe

» View Public Reports

38 reports

Spain: Brief Outlook, 2013, focus on Drug and Medication

  • Country report
  • February 2013
  • 5 pages

... And payer [20]. A canadian study showed that despite fingolimod having a greater reduc- tion in the annual relapse rate, it has the same net health benefit as treatment with interferon beta-1b [21 ...


» Read our Company Profiles

1 Companies

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.